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RNA ProcessingOnly one of these mutants did not express. Covalent
attachment to these Cys of a number of different moie-
ties—neutral, negatively charged, and even one posi-
tively charged—did not block toxin binding. Only the Regulation of gene expression by dopamine may play
attachment to the Cys of positively charged quaternary an important role in learning, reward, and addiction.
ammonium moieties blocked toxin binding (Spura et al., Hyman and colleagues now report the characteriza-
1999). A similar result was obtained with the Cys mutant tion of ania-6, a novel cyclin that associates with RNA
of L119, a residue in the complementary surface of the polymerase II and is induced by dopamine or cocaine
binding site that interacts with toxin (Sine, 1997). The in the neostriatum. Ania-6 may thus provide a link
acetylcholine binding site responds in a special way to between dopamine and gene expression at the level
quaternary ammonium groups, and the block of toxin of mRNA processing.
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identified more than 30 genes whose expression was within the cyclin box. Consistent with this, short Ania-6
was not found in nuclear speckles but exhibited a diffuseincreased rapidly in response to D1 receptor activation
(Berke et al., 1998). These included transcription factors distribution in the nucleus and cytosol.
A central feature of PolII is the presence at the C ter-and the gene products homer, narp, and arc that had
previously been identified as being induced in hippo- minus of a domain (CTD) that includes multiple repeats of
the consensus heptapeptide sequence YSPTSPS (up tocampus by seizure. The study also identified a large
number of “activity- and neurotransmitter-induced” 52 repeats in mammals) (Hirose and Manley, 2000). A
variety of protein kinases including cdk7, -8, and -9 (eachgenes (anias) whose functions were unknown. The ex-
pression of the anias was also increased by acute co- regulated by specific constitutively expressed cyclins)
interact with and can phosphorylate serines at the sec-caine and by the antipsychotic D2 receptor antagonist,
eticlopride. A general feature of their expression was ond and fifth positions in the heptapeptide repeats of
PolII, and there is likely to be a complex and heirarchicalthat it was rapid (peaks within 30–60 min) but transient
(returns to near baseline in 2–4 hr). As the authors ac- pattern of phosphorylation (and dephosphorylation) of
the CTD. The synthesis of mature mRNAs in the eukaryo-knowledged in that initial study, it seemed likely that the
task of characterizing the ania gene products would tic nucleus is an enormously complex process, with
each of the steps of initiation, 5 capping, elongation,require an extensive effort. Some of the benefits of that
effort have now been realized with the work by Hyman splicing, 3 processing, and polyadenylation, being in-
terdependent. CTD phosphorylation appears likely toand coworkers in this issue of Neuron that provides new
insights into the function and regulation of ania-6, a play an important role in all of these processes, although
different segments of the CTD and different phosphory-gene whose expression is increased robustly and tran-
siently by dopamine and cocaine (Berke et al., 2001). lation events likely play distinct roles in these various
steps of mRNA processing (Fong and Bentley, 2001).Unexpectedly, Ania-6 is shown to be a member of a
novel family of cyclins, and its discovery provides an Notably, hyperphosphorylated PolII is associated with
multiple splicing factors, and phosphorylation is associ-intriguing link between dopamine and the regulation of
RNA processing. ated with increased splicing activity. Nuclear speckles
appear to be storage compartments for proteins in-Dopamine and cocaine induce the expression of two
alternatively spliced ania-6 mRNA species. The shorter volved in mRNA processing, and hyperphosphorylated
CTD may act as a scaffold to increase the concentrationmRNA encodes a protein of Mr 60 kDa (long Ania-6),
whereas the longer mRNA incorporates a stop codon of splicing factors close to sites of transcription. Based
on its localization in speckles, the presence of the RSand encodes an ORF of 25 kDa (short Ania-6). Long
Ania-6 contains in its N terminus a domain with homol- domain, and its interaction with other splicing factors,
Hyman and colleagues reasonably hypothesize thatogy to the “cyclin box” that is characteristic of the
cyclins involved in cell cycle regulation. Long Ania-6 Ania-6/PITSLRE provides a link between dopamine and
the acute regulation of mRNA splicing. However, givendoes not interact with cdk5, -7, -8, or -9 but does interact
with an “orphan” cyclin-dependent kinase termed the the complexity of RNA transcription and processing, Ania-
6/PITSLRE may play alternative or additional roles. It will“p110 PITSLRE” kinase. The nomenclature here refers
to the specific amino acid sequence that is found in an be important to establish the precise protein:protein inter-
actions that occur between Ania-6/PITSLRE and other SRN-terminal helix in the subfamily of cyclin-dependent
protein kinases and that is important for specifying the proteins. Is Ania-6/PITSLRE an active kinase that helps to
phosphorylate PolII, or is the kinase complex recruited tointeraction with a particular cyclin.
Important clues to the potential function of Ania-6 phospho-PolII to phosphorylate splicing factors or other
proteins involved in RNA processing?come from several observations. Ania-6 is most highly
related to other cyclins known to be involved in RNA Alternative splicing can be regulated in neurons by a
number of extracellular stimuli including nerve injury,processing. Long Ania-6 also includes, at its C terminus,
potential nuclear localization motifs and a domain with kindling, and activation of neurotransmittter receptors
(Dredge et al., 2001; Grabowski and Black, 2001). Inhomology to so-called “SR proteins,” proteins that con-
tain multiple arginine/serine (RS) dipeptide repeats and addition to dopamine, Ania-6 may possibly be involved
in regulation of splicing in response to other neuronalthat are localized to so-called “nuclear speckles.” Nota-
bly, the p110 PITSLRE isoforms themselves are enriched stimuli. Ania-6 may also work together with additional
regulatory factors. Neuron-specific splicing factors likein nuclear speckles, probably in complexes with other
SR proteins involved in splicing. Consistent with the NOVA have been identified, and pathways involving Ca2
and cGMP are likely to be involved in regulation of splic-presence of nuclear localization and RS motifs, long
Ania-6 was shown to be enriched in nuclear speckles ing. A central component of dopamine signaling in neo-
striatum involves the D1/PKA/DARPP-32 pathway thatwhere it colocalized with another SR protein, termed
SC-35, a splicing factor known to be associated with the regulates the multifunctional protein phosphatase, PP1.
PP1 is involved in dephosphorylation events that controlhyperphosphorylated form of RNA polymerase II (phospho-
PolII). Furthermore, immunoprecipitation studies showed mRNA splicing (Misteli, 2000); thus, regulation of PP1
by the DARPP-32 pathway might contribute to the con-that long Ania-6 also associated with the phospho- but
not the dephospho-form of PolII. (It should be noted trol of splicing by dopamine in the neostriatum.
What might be the potential physiological significancethat preliminary results support the idea that Ania-6 may
directly interact with SC-35, so the interaction with phos- of a link between dopamine and mRNA splicing? Alter-
native splicing is a common feature in the nervous sys-pho-PolII may be indirect.) Notably, short Ania-6 does
not appear to interact with PITSLRE kinase, presumably tem, and examples include the production of isoforms of
neurotransmitter receptors, ion channels, and proteinsbecause the 25 kDa form of the protein is truncated
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and enzymes involved in signal transduction. In other regulation of PolII. It will be important to elucidate the
examples, such as neurexin and cadherin, there is the signaling mechanisms that link dopamine and glutamate
possibility to generate thousands of different splice to the alternative splicing of ania-6 itself. The PITSLRE
forms from a single gene. Differential splicing in neurons kinase has recently been implicated in the death of do-
may therefore rival the immune system and contribute to paminergic neurons (Chun et al., 2001). Therefore, in
the diversity and specificity necessary for the complex addition to normal regulation of RNA processing, Ania-6
interneuronal communication found in the CNS. The ex- may be linked to neuropathological changes in dopa-
pression of isoforms of D2, NMDA, and AMPA receptors minergic signaling. Characterization of the other ania
involves alternative splicing and may provide targets genes will likely open up additional new and exciting
in the striatum for regulation by dopamine via Ania-6/ avenues of research.
PISTLRE. Aberrant splicing also appears to play a role
in a variety of neurological diseases, including fronto- Angus C. Nairn1,2 and Paul Greengard1
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Interestingly, mRNAs for several anias, including Rockefeller University
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selves alternatively spliced. While the long and short 2 Department of Psychiatry
ania-6 mRNAs are induced by D1 agonists and cocaine, Yale University
glutamate increases expression only of the mRNA that New Haven, Connecticut 06520
produces the short, truncated form of the protein. It
will be of interest to determine whether the effect of
Selected Readingglutamate involves NMDA, AMPA, or metabotropic re-
ceptors. If it is expressed as a functional protein, short
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J. Biol. Chem., in press. Published online September 14, 2001.
manner and influence the RNA processing for other gene 10.1074/jbc.M106460200.
products. Clearly differential effects of dopamine and
Berke, J.D., Paletzki, R.F., Aronson, G.J., Hyman, S.E., and Gerfen,
glutamate on ania-6 mRNA splicing may possibly play C.R. (1998). J. Neurosci. 18, 5301–5310.
a role in the complex interactions between dopamine Berke, J.D., Sgambato, V., Zhu, P.P., Lavoie, B., and Vincent, M.,
and glutamate in the neostriatum. Krause, M., and Hyman, S.E. (2001). Neuron 32, this issue, 277–287.
The characterization of Ania-6 further highlights a role Bibb, J.A., Chen, J., Taylor, J.R., Svenningsson, P., Nishi, A., Snyder,
for so-called “cyclin-dependent” protein kinases in the G.L., Yan, Z., Sagawa, Z.K., Ouimet, C.C., Nairn, A.C., et al. (2001).
Nature 410, 376–380.brain. Much attention has been focused on cdk5, a
multifunctional kinase that is involved in both CNS de- Chun, H.S., Gibson, G.E., DeGiorgio, L.A., Zhang, H., Kidd, V.J., and
Son, J.H. (2001). J. Neurochem. 76, 1010–1021.velopment and in many signal transduction pathways
Dredge, B.K., Polydorides, A.D., and Darnell, R.B. (2001). Nat. Rev.in postmitotic neurons (Smith et al., 2001). Increased
Neurosci. 2, 43–50.expression of cyclins and cdks normally associated with
Fong, N., and Bentley, D.L. (2001). Genes Dev. 15, 1783–1795.regulation of the cell cycle is found at the sites of cell
Grabowski, P.J., and Black, D.L. (2001). Prog. Neurobiol. 65,death in neurodegenerative diseases such as Alzhei-
289–308.mer’s disease (AD) (Husseman et al., 2000). Important
Greengard, P., Allen, P.B., and Nairn, A.C. (1999). Neuron 23,links to AD include the fact that both tau and the amyloid
435–447.precursor protein (Ando et al., 2001) are substrates for
Hirose, Y., and Manley, J.L. (2000). Genes Dev. 14, 1415–1429.cdk5. Other novel cdks have been identified in brain
Husseman, J.W., Nochlin, D., and Vincent, I. (2000). Neurobiol. Agingincluding the KKIAMRE kinase that is induced in cerebel-
21, 815–828.lum of rabbits during eyeblink conditioning. Cdk9 is
Misteli, T. (2000). J. Cell Sci. 113, 1841–1849.highly expressed in brain and may also be involved in
Nestler, E.J. (2001). Nat. Rev. Neurosci. 2, 119–128.regulation of PolII function through its ability to phos-
Smith, D.S., Greer, P.L., and Tsai, L.H. (2001). Cell Growth Differ.phorylate the CTD.
12, 277–283.Hyman and colleagues show clearly that the induction
of ania-6 by dopamine is rapid and transient. An acute
dose of cocaine also induced rapid and transient ex-
pression of ania-6. A recent series of studies have pro-
vided evidence that links chronic cocaine treatment to
expression of cdk5 and suggests a mechanism involving
phosphorylation of DARPP-32 whereby cdk5 influences
dopaminergic signaling and the behavioral actions of
the psychostimulant (Bibb et al., 2001). It will be interest-
ing to examine the effects of chronic cocaine on ania-6
and to determine whether changes in RNA processing
might also be involved in longer-term adaptive changes
that accompany drug addiction.
The studies by Hyman and colleagues represent an
important first step in characterizing the regulation by
dopamine of Ania-6/PITSLRE kinase in the neostriatum.
Future studies will undoubtedly include an effort to un-
derstand the precise function of Ania-6 with respect to
